Prognostic Significance of cyclin D1, β-catenin, and MTA1 in Patients with Invasive Ductal Carcinoma of the Breast
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Significance of cyclin D1, β-catenin, and MTA1 in Patients with Invasive Ductal Carcinoma of the Breast
Authors
Keywords
-
Journal
ANNALS OF SURGICAL ONCOLOGY
Volume 19, Issue 13, Pages 4129-4139
Publisher
Springer Nature
Online
2012-08-02
DOI
10.1245/s10434-012-2541-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma
- (2012) Shiang-Fu Huang et al. World Journal of Surgical Oncology
- Cyclin D1, Id1 and EMT in breast cancer
- (2011) Nicholas P Tobin et al. BMC CANCER
- Subtype-specific alterations of the Wnt signaling pathway in breast cancer: Clinical and prognostic significance
- (2011) Nupur Mukherjee et al. CANCER SCIENCE
- Nuclear beta-catenin overexpression in metastatic sentinel lymph node is associated with synchronous liver metastasis in colorectal cancer
- (2011) Hongxia Cheng et al. Diagnostic Pathology
- Epithelial-mesenchymal interactions in breast cancer: evidence for a role of nuclear localized β-catenin in carcinoma-associated fibroblasts
- (2011) Eldo T Verghese et al. HISTOPATHOLOGY
- Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study
- (2011) Maria Grazia Prisco et al. HUMAN PATHOLOGY
- The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
- (2011) Taj D. King et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Metastasis-Associated Protein 1 and Its Short Form Variant Stimulates Wnt1 Transcription through Promoting Its Derepression from Six3 Corepressor
- (2010) R. Kumar et al. CANCER RESEARCH
- Diverse Associations between ESR1 Polymorphism and Breast Cancer Development and Progression
- (2010) S.-l. Ding et al. CLINICAL CANCER RESEARCH
- Identification of Subtypes in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome
- (2010) Johan Staaf et al. JOURNAL OF CLINICAL ONCOLOGY
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression
- (2010) Douglas S. Micalizzi et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Common Genetic Variation in Candidate Genes and Susceptibility to Subtypes of Breast Cancer
- (2009) N. Mavaddat et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Molecular Subtypes of Breast Cancer Emerging in Young Women in Taiwan: Evidence for More Than Just Westernization as a Reason for the Disease in Asia
- (2009) C.-H. Lin et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes
- (2009) Jyh-Cherng Yu et al. CARCINOGENESIS
- The clinical implications of MMP-11 and CK-20 expression in human breast cancer
- (2009) Chun-Wen Cheng et al. CLINICA CHIMICA ACTA
- The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications
- (2009) Yasushi Toh et al. CLINICAL & EXPERIMENTAL METASTASIS
- Gene-Expression Signatures in Breast Cancer
- (2009) Christos Sotiriou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methylation of CpG islands of p16INK4a and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast
- (2008) Tieju Liu et al. HUMAN PATHOLOGY
- Basal-Like Breast Cancer: A Critical Review
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic alterations of CDH1 and APC genes: Relationship with activation of Wnt/β-catenin Pathway in invasive ductal carcinoma of breast
- (2008) Chandra P. Prasad et al. LIFE SCIENCES
- Molecular Basis of Metastasis
- (2008) Anne C. Chiang et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started